Kuldip Dave, Vice President of Research, ALS Association
Dr. Dave is a former director of research programs at The Michael J. Fox Foundation for Parkinson’s Research, where he developed and implemented the Foundation’s ambitious research vision in the biology of Parkinson’s. He convened scientists from academe and the pharmaceutical industry to fund promising research opportunities, and he was deeply involved in advancing the study of alpha-synuclein, a protein linked to Parkinson’s disease.
“Dr. Dave will lead The ALS Association’s global research program, ensuring transparency, accountability and impact across our extensive research portfolio,” said Neil Thakur, executive vice president, mission strategy. “In his new capacity, he will ensure that that the Association continues to drive research that improves the lives of people with ALS and helps us find a cure.”
Dr. Dave received his undergraduate degree in biology from Rutgers University, and a Ph.D. in pharmacology and physiology from Drexel University College of Medicine. He completed a post-doctoral fellowship at a biotechnology firm and later joined the pharmaceutical company Wyeth, where he was the biology team leader for programs in the Women’s Health Department. He later moved to Galleon Pharmaceuticals as a senior research scientist. Dr. Dave lives in Spotswood, New Jersey.